Search
2024
2023
-
Feb 02, 2024
YolTech Announces Appointment of Tony W.Ho as Scientific AdvisorRead More
-
Dec 14, 2023
First Patient Dosed in Clinical Trial of YOLT-201 for ATTR-CMRead More
-
Dec 11, 2023
YolTech’s Founder Interviewed by UCB China Voice JournalRead More
-
Dec 06, 2023
YolTech Announces NMPA Acceptance of IND Application for YOLT-201 to Treat hATTRRead More
-
Dec 01, 2023
YolTech Secured $15 Million in Series A+ FinancingRead More
